NCT06609369View on ClinicalTrials.gov

Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse

PHASE2RecruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

April 21, 2025

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions
Tobacco UseTobacco CessationInsomnia
Interventions
BEHAVIORAL

Experimental health intervention

Behavioral health intervention

DRUG

Varenicline

Days 1-3: 0.5mg once daily, Days 4-7: 0.5mg twice daily; Days 8-56: 1.0mg twice daily.

Trial Locations (2)

06519

RECRUITING

Connecticut Mental Health Center, New Haven

06520

RECRUITING

Yale University, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER